RxSight Inc (RXST)

45.05 +0.24 (+0.54%) USD  |  NASDAQ  |  Nov 21, 16:00
45.03 -0.02 (-0.04%) After-Hours: 20:00
More

RxSight EPS Diluted (Quarterly): -0.16 for Sept. 30, 2024

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Upgrade now.
Date Value
September 30, 2024 -0.16
June 30, 2024 -0.16
March 31, 2024 -0.25
December 31, 2023 -0.25
September 30, 2023 -0.35
June 30, 2023 -0.40
March 31, 2023 -0.42
December 31, 2022 -0.56
September 30, 2022 -0.61
June 30, 2022 -0.61
Date Value
March 31, 2022 -0.64
December 31, 2021 -0.58
September 30, 2021 -0.68
June 30, 2021 -0.5125
March 31, 2021 -0.3568
December 31, 2020 0.9573
September 30, 2020 0.3093
June 30, 2020 -0.8902
March 31, 2020 -1.088

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-1.088
Minimum
Mar 2020
0.9573
Maximum
Dec 2020
-0.3816
Average
-0.42
Median
Mar 2023

EPS Diluted (Quarterly) Benchmarks

Tandem Diabetes Care Inc -0.35
Perspective Therapeutics Inc -0.21
Retractable Technologies Inc -0.07
Xtant Medical Holdings Inc -0.04
Catheter Precision Inc -2.01

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -6.338M
Revenue (Quarterly) 35.31M
Total Expenses (Quarterly) 44.54M
Enterprise Value 1.579B
Gross Profit Margin (Quarterly) 71.42%
Profit Margin (Quarterly) -17.95%
Earnings Yield -1.82%
Normalized Earnings Yield -1.820